Michael Green MD
Thoracic Cancer, Urologic Cancer
Assistant Professor, University of Michigan; Attending Physician, Veterans Affairs Ann Arbor Hospital System; Principal Investigator, Department of Radiation Oncology
Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a physician scientist who clinically focuses on the treatment of cancer with radiation. My career goal is to discovery more effective treatments for cancer patients.
Education & Training
- University of MichiganResidency, Radiation Oncology, 2014 - 2019
- Icahn School of Medicine at Mount SinaiClass of 2014
Certifications & Licensure
- AK State Medical License 2024 - 2026
- MI State Medical License 2015 - 2026
- PA State Medical License 2014 - 2015
- American Board of Radiology Radiation Oncology
Clinical Trials
- Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer Start of enrollment: 2022 Jun 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.Yupei Guo, Zian Li, Leslie A Parsels, Zhuwen Wang, Joshua D Parsels
Neuro-Oncology. 2025-04-10 - Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System.Sean R Miller, Rachel Tucker Gonzalez, William C Jackson, Megan E V Caram, Phoebe A Tsao
Journal of Nuclear Medicine. 2025-01-03 - Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer.Victoria M Valvo, Qiang Zhang, Long Jiang, Erin A Holcomb, Ashley N Pearson
Molecular Cancer Therapeutics. 2024-12-17
Press Mentions
- Lung Cancer Screening Prolongs Lives in Real-World StudyJune 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: